Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study-Reference-Cited by-同舟云学术

Selecting the best machine learning algorithm to support the diagnosis of Non-Alcoholic Fatty Liver Disease: A meta learner study

Published:2020-10-20 Issue:10 Volume:15 Page:e0240867
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sorino Paolo,Caruso Maria Gabriella,Misciagna Giovanni,Bonfiglio Caterina,Campanella Angelo,Mirizzi Antonella,Franco Isabella,Bianco Antonella,Buongiorno Claudia,Liuzzi Rosalba,Cisternino Anna Maria,Notarnicola Maria,Chiloiro Marisa,Pascoschi Giovanni,Osella Alberto Rubén^ORCID,

Funder

Ministry of Health, Italy

Apulia Region

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Epidemiology and natural history of non-alcoholic fatty liver disease;Y Fazel;Metabolism,2016

2. The epidemiology, pathogenesis and histopathology of fatty liver disease;AP Levene;Histopathology,2012

3. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;ZM Younossi;Hepatology,2016

4. Epidemiology of HCV infection in the general population: a survey in a southern Italian town;R Cozzolongo;The American journal of gastroenterology,2009

5. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference;BA Neuschwander-Tetri;Hepatology,2003

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ARIEL: Brain-Computer Interfaces meet Large Language Models for Emotional Support Conversation;Adjunct Proceedings of the 32nd ACM Conference on User Modeling, Adaptation and Personalization;2024-06-27

2. Evolutive Models, Algorithms and Predictive Parameters for the Progression of Hepatic Steatosis;Metabolites;2024-04-03

3. Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information;PLOS ONE;2024-02-29

4. Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction‐associated steatotic liver disease – The Gut and Obesity in Asia (GO‐ASIA) Study;Alimentary Pharmacology & Therapeutics;2024-02

5. AI-Powered Automated Methods for Predicting Liver Disease: A Recent Review;Communications in Computer and Information Science;2024